Browsing by Author Van Gaal, L

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)Citation
2009Acute effect of weight loss on levels of total bilirubin in obese, cardiovascular high-risk patients: an analysis from the lead-in period of the Sibutramine Cardiovascular Outcome trialCaterson, Ian; Andersson, Charlotte; Brendorp, Bente; Coutinho, Walmir; Finer, Nick; Fosbol, Emil Loldrup; Kober, Lars; Sharma, Arya; Van Gaal, L; Weeke, Peter; Boden InstituteAcute effect of weight loss on levels of total bilirubin in obese, cardiovascular high-risk patients: an analysis from the lead-in period of the Sibutramine Cardiovascular Outcome trial, Metabolism: clinical and experimental, vol.58, 8, 2009,pp 1109-1115
2007Additive effects of weight loss and sibutramine in managing hypertensive patients - An analysis of the sibutramine cardiovascular outcomes (SCOUT) trialCaterson, Ian; Coutinho, Walmir; Finer, Nick; James, P; Maggioni, Aldo Pietro; Sharma, Arya M; Torp-Pedersen, Christian; Van Gaal, L; School of Molecular BioscienceAdditive effects of weight loss and sibutramine in managing hypertensive patients - An analysis of the sibutramine cardiovascular outcomes (SCOUT) trial, Journal of Hypertension. Supplement, vol.25,(N/A),2007,pp S290-S290
2009Blood pressure changes associated with sibutramine and weight management - an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes trial (SCOUT)Caterson, Ian; Bacher, H; Coutinho, Walmir; Finer, Nick; James, W; Maggioni, Aldo; Sharma, Arya; Shepherd, Gillian; Torp-Pedersen, Christian; Van Gaal, L; Boden InstituteBlood pressure changes associated with sibutramine and weight management - an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes trial (SCOUT), Diabetes, Obesity and Metabolism, vol.11, N/A, 2009,pp 239-250
2007Initial blood pressure response of high-risk patients with diabetes plus cardioavascular disease after 6-weeks Sibutramine treatment - an analysis of the Sibutramine Cardiovascular Outcomes (SCOUT) TrialCaterson, Ian; Coutinho, W; Finer, Nick; James, W. P. T.; Maggioni, Aldo Pietro; Sharma, A; Torp-Pedersen, C; Van Gaal, L; Molecular & Microbial BioscienInitial blood pressure response of high-risk patients with diabetes plus cardioavascular disease after 6-weeks Sibutramine treatment - an analysis of the Sibutramine Cardiovascular Outcomes (SCOUT) Trial, Diabetologia: clinical and experimental diabetes and metabolism, vol.50,(suppl1),2007,pp s346-s346
2012Relationship between HbA1c levels and risk of cardiovascular adverse outcomes and all-cause mortality in overweight and obese cardiovascular high-risk women and men with type 2 diabetesCaterson, Ian; Andersson, Charlotte; Couthino, W.; Finer, Nick; James, W; Maggioni, Aldo; Sharma, Arya; Torp-Pedersen, Christian; Van Gaal, L; Weeke, Peter; Boden InstituteRelationship between HbA1c levels and risk of cardiovascular adverse outcomes and all-cause mortality in overweight and obese cardiovascular high-risk women and men with type 2 diabetes, Diabetologia: clinical and experimental diabetes and metabolism, vol.55, 9, 2012,pp 2348-2355